---

---

symbols : NVO    exchanges : Nasdaq   

save search

---

Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 3.69% | O: 0.24% H: 0.42% C: 0.42%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 3.3% | O: -0.84% H: 0.86% C: -0.62%
GSK | News | $40.755 -1.18% 660K |

Health Technology

| 4.14% | O: -0.56% H: 0.0% C: 0.0%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| -1.56% | O: -0.21% H: 0.11% C: -3.05%
AZN | News | $71.065 0.3% 3.2M |

Health Technology

| 3.79% | O: -0.18% H: 0.84% C: 0.6%
report reach therapeutics market

---

Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published: 2024-03-13 (Crawled : 18:00) - prnewswire.com
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| -4.79% | O: -0.64% H: 0.94% C: -0.56%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| -7.28% | O: 0.66% H: 0.0% C: 0.0%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| -2.11% | O: 0.27% H: 0.5% C: 0.11%
ABT | News | $106.78 -0.75% 2M |

Health Technology

| -10.48% | O: 0.41% H: 0.0% C: 0.0%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| -2.65% | O: -0.04% H: 0.0% C: 0.0%
report distribution year global market

---

Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published: 2024-02-23 (Crawled : 17:00) - prnewswire.com
NVSEF | News | $96.0 52K |

Health Technology

| -6.68% | O: 0.37% H: 0.58% C: 0.58%
VTRS | News A | $11.37 0.09% 1.2M |

Health Technology

| -14.97% | O: 0.0% H: 1.93% C: 1.27%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 3.31% | O: -0.68% H: 0.4% C: -0.18%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| -3.83% | O: 0.89% H: 0.4% C: 0.17%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| -6.72% | O: 0.28% H: 0.0% C: 0.0%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| -1.78% | O: 0.97% H: 0.0% C: 0.0%
report revenue global insulin growth market

---

Transthyretin Amyloidosis Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Players - Attralus, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Novo Nordisk
Published: 2024-01-24 (Crawled : 23:00) - prnewswire.com
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 22.27% | O: 0.49% H: 0.0% C: -0.05%
IONS | $42.1 0.62% 290K |

Health Technology

| -17.31% | O: 0.38% H: 2.34% C: 1.56%
key growth market

---

Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics
Published: 2024-01-17 (Crawled : 22:00) - prnewswire.com
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 20.58% | O: -0.36% H: 1.32% C: 1.18%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| -6.62% | O: -0.21% H: 0.0% C: 0.0%
VRTX | $401.7 -0.79% 280K |

Health Technology

| -6.65% | O: -0.5% H: 0.76% C: 0.32%
EDIT | News | $5.375 -1.56% 590K |

Health Technology

| -35.08% | O: 0.83% H: 0.35% C: -3.66%
AGIO | $31.57 -0.75% 100K |

Health Technology

| 46.52% | O: 0.41% H: 0.0% C: -2.2%
crispr companies therapeutics growth study market

---

Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| -9.46% | O: 1.1% H: 0.0% C: 0.0%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 18.38% | O: -0.33% H: 0.35% C: -1.5%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 17.27% | O: 0.67% H: 0.85% C: 0.21%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| -9.47% | O: 0.69% H: 0.0% C: 0.0%
ALDX | $3.885 -0.64% 230K |

Health Technology

| 17.07% | O: -1.8% H: 0.46% C: -2.44%
companies therapeutics growth market

---

Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
Published: 2024-01-08 (Crawled : 13:30) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 3.42% | O: 2.71% H: 0.36% C: 0.11%
LEXX | $2.24 33K |

Health Technology

| 65.93% | O: 0.0% H: 8.15% C: 1.48%
PFE | News 4 | $26.25 -0.27% 9.9M |

Health Technology

| -10.69% | O: -0.37% H: 1.09% C: 0.75%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 21.38% | O: 0.19% H: 0.34% C: 0.21%
MRK | $126.585 -0.23% 2M |

Health Technology

| 8.24% | O: 0.32% H: 0.26% C: -0.18%
AZN | News | $71.065 0.3% 3.2M |

Health Technology

| 3.61% | O: 0.28% H: 0.99% C: 0.93%

---

Novo Nordisk enters into research collaborations with Omega Therapeutics and Cellarity on novel treatment approaches for cardiometabolic diseases
Published: 2024-01-04 (Crawled : 11:00) - globenewswire.com
OMGA | $2.275 -2.78% 35K |

| -14.29% | O: 92.31% H: 20.0% C: 1.24%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 24.15% | O: 1.44% H: 3.68% C: 2.4%
treatment research therapeutics

---

Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| -1.63% | O: 3.66% H: 0.0% C: -0.12%
AZNCF | News | $140.3 1.5K |

Health Technology

| 7.51% | O: 3.33% H: 0.0% C: -2.93%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 24.31% | O: -0.31% H: 0.39% C: -0.44%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| -2.51% | O: 1.09% H: 0.0% C: 0.0%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 29.2% | O: 0.18% H: 0.5% C: -0.46%
BMY | $48.76 -0.47% 3.9M |

Health Technology

| -4.43% | O: -0.78% H: 5.15% C: 2.81%
ABBV | News | $168.51 -0.61% 920K |

Health Technology

| 11.11% | O: 0.58% H: 0.0% C: 0.0%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| -3.43% | O: 1.03% H: 0.0% C: 0.0%
REGN | News | $909.33 0.22% 140K |

Health Technology

| 7.77% | O: 0.52% H: 0.58% C: 0.05%
GILD | $67.03 2.4M |

Health Technology

| -15.08% | O: 0.34% H: 1.02% C: 0.59%
BIIB | $202.7 4.93% 1.6M |

Health Technology

| -23.9% | O: 0.57% H: 1.36% C: 1.04%
AZN | News | $71.065 0.3% 3.2M |

Health Technology

| 6.86% | O: 1.06% H: 0.18% C: -1.06%
AMGN | News | $274.065 0.19% 570K |

Health Technology

| -2.07% | O: 0.24% H: 2.03% C: 1.49%
patent report global market

---

Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 29.97% | O: 0.91% H: 0.72% C: 0.11%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| -2.87% | O: 0.45% H: 0.0% C: 0.0%
IPHA | $2.37 170 |

Health Technology

| -3.27% | O: 13.88% H: 0.0% C: -3.58%
pharma natural cell sanofi

---

Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 1.5K |

Health Technology

| 5.89% | O: -3.0% H: 2.15% C: 2.15%
NVSEF | News | $96.0 52K |

Health Technology

| -2.04% | O: 0.0% H: 0.0% C: 0.0%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 31.27% | O: -0.48% H: 0.0% C: -0.44%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| -0.01% | O: -1.31% H: 0.56% C: -0.17%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 24.49% | O: -4.44% H: 0.0% C: 0.0%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| -2.57% | O: -0.93% H: 0.0% C: 0.0%
AZN | News | $71.065 0.3% 3.2M |

Health Technology

| 6.78% | O: -2.23% H: 0.28% C: -0.11%
reach research market

---

Liberty All-Star Equity Fund November 2023 Monthly Update
Published: 2023-12-13 (Crawled : 18:00) - prnewswire.com
SNEJF | News | $81.888 42K |

Consumer Durables

| -9.7% | O: -0.26% H: 3.39% C: 3.39%
SKX 4 | $59.02 -1.04% 900K |

Consumer Non-Durables

| -3.04% | O: 1.19% H: 1.61% C: 0.58%
NOW | $741.0 0.01% 530K |

Technology Services

| 3.54% | O: -0.79% H: 0.3% C: -4.17%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 30.07% | O: -0.38% H: 0.21% C: -0.53%
IQV | $238.625 770K |

Health Services

| 5.61% | O: 0.35% H: 3.61% C: 1.68%
SWKS 4 | $100.73 1.44% 620K |

Electronic Technology

| -8.87% | O: 0.94% H: 3.45% C: 3.11%
REGN | News | $909.33 0.22% 140K |

Health Technology

| 3.56% | O: -0.26% H: 0.56% C: 0.25%
PYPL 4 | $64.5 0.11% 3.8M |

Technology Services

| 4.37% | O: 1.96% H: 1.89% C: -1.7%
ADSK | $214.64 -1.51% 730K |

Technology Services

| -7.23% | O: 0.19% H: 3.09% C: 2.32%
AMZN S | $176.37 -1.77% 15M |

Retail Trade

| 20.63% | O: 0.73% H: 0.41% C: -1.67%
update liberty

---

Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.5 1.2K |

Health Technology

| -23.05% | O: -2.79% H: 0.62% C: 0.62%
SNYNF | News | $94.25 480 |

Health Technology

| 4.05% | O: 2.06% H: 0.82% C: 0.82%
NVSEF | News | $96.0 52K |

Health Technology

| -0.9% | O: -1.29% H: 0.4% C: 0.4%
ALPMY | News | $9.49 480K |

Manufacturing

| -22.59% | O: -2.2% H: 0.0% C: -0.27%
TAK | News | $13.215 -1.23% 410K |

Health Technology

| -5.22% | O: -0.64% H: 0.5% C: 0.5%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 32.88% | O: -0.42% H: 0.67% C: 0.25%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| 3.05% | O: 0.19% H: 0.35% C: 0.2%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| -4.05% | O: -0.18% H: 0.0% C: 0.0%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 25.99% | O: 0.43% H: 0.0% C: 0.0%
BMY | $48.76 -0.47% 3.9M |

Health Technology

| -2.33% | O: 0.2% H: 0.55% C: 0.1%
ABBV | News | $168.51 -0.61% 920K |

Health Technology

| 14.72% | O: 0.3% H: 0.0% C: 0.0%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| 2.93% | O: 1.07% H: 0.0% C: 0.0%
GILD | $67.03 2.4M |

Health Technology

| -14.12% | O: 0.08% H: 1.45% C: 1.17%
AMGN | News | $274.065 0.19% 570K |

Health Technology

| 0.82% | O: -0.05% H: 0.3% C: -0.76%
reach market

---

PDS Biotech Appoints Lars Boesgaard as Chief Financial Officer
Published: 2023-11-28 (Crawled : 12:30) - globenewswire.com
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 23.85% | O: -1.93% H: 0.37% C: -0.43%
PDSB | $3.265 2.03% 260K |

Health Technology

| -45.76% | O: -3.39% H: 0.7% C: -6.49%
PODD | $166.315 -0.57% 230K |

Health Technology

| -10.9% | O: -0.87% H: 1.19% C: -0.21%
biotech financial

---

Type 1 Diabetes Market to Accelerate Substantially During the Study Period (2019-2032), Predicts DelveInsight | Leading Companies Developing Therapies - Eli Lilly, Vertex, Bayer, Novo Nordisk, Rise, Tolerion, BioKier, Dompé Farmaceutici
Published: 2023-11-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $94.25 480 |

Health Technology

| 6.69% | O: 3.37% H: 1.29% C: 1.29%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 33.4% | O: 2.62% H: 0.67% C: 0.58%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 21.05% | O: -3.12% H: 0.61% C: -0.46%
VRTX | $401.7 -0.79% 280K |

Health Technology

| 15.91% | O: 0.4% H: 0.38% C: -2.2%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| 3.75% | O: 1.54% H: 0.0% C: 0.0%
companies diabetes study market

---

Global Glucagon-like Peptide 1 (GLP-1) Market Report 2023: Key Players Include Pfizer Inc., AstraZeneca PLC, Sanofi, Novo Nordisk Among Others
Published: 2023-11-11 (Crawled : 04:20) - prnewswire.com
SNY | News | $46.615 -2.25% 730K |

Health Technology

| Email alert Add to watchlist
LLY | News | $731.81 -1.86% 1M |

Health Technology

| Email alert Add to watchlist
AZN | News | $71.065 0.3% 3.2M |

Health Technology

| Email alert Add to watchlist
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 1.5K |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $94.25 480 |

Health Technology

| Email alert Add to watchlist
report astrazeneca global market

---

Addressing the Global HIV Challenge: Market for Diagnostics and Therapeutics Plays a Crucial Role in Combating HIV/AIDS
Published: 2023-11-03 (Crawled : 17:00) - prnewswire.com
TRUMF | $16.608 5.6K |

Health Technology

| -40.08% | O: -0.28% H: 4.55% C: 0.01%
SNYNF | News | $94.25 480 |

Health Technology

| 1.89% | O: -1.79% H: 0.0% C: 0.0%
NVSEF | News | $96.0 52K |

Health Technology

| 2.95% | O: -1.88% H: 3.51% C: 2.73%
TRUMY | $17.05 47K |

Manufacturing

| -39.65% | O: 3.89% H: 0.0% C: -1.74%
TMO | News | $568.365 -1.08% 680K |

Health Technology

| 27.24% | O: 2.32% H: 0.0% C: 0.0%
QGEN | $41.39 -1.19% 450K |

Health Technology

| 9.58% | O: 2.12% H: 1.06% C: 0.51%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 27.45% | O: -2.23% H: 0.16% C: -0.52%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| 5.08% | O: -1.4% H: 0.42% C: 0.0%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| 1.36% | O: 2.15% H: 0.0% C: 0.0%
BDX | $234.225 -0.06% 330K |

Health Technology

| -8.42% | O: 1.1% H: 0.33% C: 0.07%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| 0.11% | O: -3.04% H: 0.0% C: 0.0%
QGEN | $41.39 -1.19% 450K |

Health Technology

| 9.58% | O: 2.12% H: 1.06% C: 0.51%
global hiv diagnostics therapeutics market

---

Medical Segment Dominates, Expected to Reach $70.4 Billion by 2030 in the Global Recombinant DNA Technology Market
Published: 2023-11-01 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 2.6K |

Health Technology

| 8.56% | O: -1.62% H: 0.0% C: 0.0%
SNYNF | News | $94.25 480 |

Health Technology

| 5.47% | O: 0.94% H: 2.55% C: 2.55%
NVSEF | News | $96.0 52K |

Health Technology

| 5.59% | O: 2.52% H: 0.04% C: 0.04%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 33.21% | O: 0.87% H: 0.73% C: 0.28%
NVS | News | $97.755 0.49% 1.1M |

Health Technology

| 5.64% | O: 0.16% H: 0.7% C: 0.57%
GSK | News | $40.755 -1.18% 660K |

Health Technology

| 15.52% | O: -4.06% H: 1.9% C: 0.96%
LLY | News | $731.81 -1.86% 1M |

Health Technology

| 30.05% | O: -2.76% H: 0.0% C: 0.0%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| 3.29% | O: 0.18% H: 0.0% C: 0.0%
expected reach global dna medical technology market

---

EMIS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Emisphere Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2023-10-26 (Crawled : 01:00) - prnewswire.com
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 32.03% | O: -1.47% H: 0.22% C: -0.83%
DMTK 4 | $0.616 26K |

Health Technology

| -49.18% | O: -1.64% H: 1.67% C: -1.67%

---

Global Bleeding Disorders Treatment Market Surpasses $14 Billion in 2022, Expected to Reach $20.3 Billion by 2028
Published: 2023-10-25 (Crawled : 22:00) - prnewswire.com
TAK | News | $13.215 -1.23% 410K |

Health Technology

| -7.97% | O: -4.69% H: 0.69% C: -3.18%
NVO | News | $125.45 -2.48% 1.8M |

Health Technology

| 32.03% | O: -1.47% H: 0.22% C: -0.83%
JNJ | News | $148.22 -0.9% 3.3M |

Health Technology

| -1.26% | O: 0.1% H: 0.0% C: 0.0%
SNY | News | $46.615 -2.25% 730K |

Health Technology

| -11.36% | O: 0.09% H: 0.0% C: 0.0%
bleeding expected reach disorders treatment global market

---

Gainers vs Losers

54%

46%

Top 10 Gainers

CSSE 4 | $0.3499 129.74% 150M |

Consumer Services

CZOO | $11.04 121.24% 9.6M |

BOF | $2.05 75.21% 78M |

AMST | $3.2 60.0% 63M |

Technology Services

LICN | $0.8592 53.43% 13M |

WIMI | $1.05 44.75% 13M |

Technology Services

TROO | $1.51 38.53% 5.6M |

Manufacturing

MULN | News | $3.675 34.62% 11M |

Information

RILY | $28.605 31.7% 9.9M |

Finance

RBBN 4 | $3.305 28.6% 1.9M |

Electronic Technology

---

Your saved searches

---